Kon, Tomoya
Forrest, Shelley L.
Lee, Seojin
Martinez‑Valbuena, Ivan
Li, Jun
Nassir, Nasna
Uddin, Mohammed J.
Lang, Anthony E.
Kovacs, Gabor G.
Funding for this research was provided by:
Rossy Family Foundation
Edmond J. Safra Philanthropic Foundation
Canada Foundation for Innovation (40480)
National Health and Medical Research Council of Australia Ideas grant (214090508)
Article History
Received: 19 September 2023
Accepted: 10 November 2023
First Online: 23 November 2023
Declarations
:
: This study was approved by the University Health Network (UHN) Research Ethics Board (Nr. 20-5258) and the University of Toronto (Nr. 39459) and was performed per ethical standards established in the 1964 Declaration of Helsinki, updated in 2008.
: Not applicable.
: GGK holds shared patent for the 5G4 antibody. All other authors declare that they have no competing interests regarding this study.